Chronic myeloid leukaemia and tuberculosis in a patient with rheumatoid arthritis treated with infliximab

Annals of the Rheumatic Diseases

Volumn 64, Issue 3, 2005, Pages 509-510

  Broussais, F ^a   Kawashima, M ^a   Marotte, H ^a   Miossec, P ^a,b  

^a BIOMÉRIEUX   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; HYDROXYUREA; IMATINIB; INFLIXIMAB; ISONIAZID; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; RIFAMPICIN;

ADULT; ARTHRALGIA; ARTICLE; BONE MARROW BIOPSY; BRONCHITIS; CASE REPORT; CHRONIC MYELOID LEUKEMIA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; HUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; THROMBOCYTE COUNT; THROMBOCYTOSIS; TUBERCULOSIS; WEIGHT REDUCTION;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MIDDLE AGED; TUBERCULOSIS, PULMONARY;

EID: 14144255209     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2004.021378     Document Type: Article

References (6)

1. Brown SL, Greene MH, Gershon SK, Edwards ET, Braun MM. Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum 2002;46:3151-8.
2. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001;345:1098-104.
3. Maini R, St Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, et al. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group. Lancet 1999;354:1932-9.
4. Bakland G, Nossent H. Acute myelogenous leukaemia following etanercept therapy. Rheumatology (Oxford) 2003;42:900-1.
5. Ekstrom K, Hjalgrim H, Brandt L, Baecklund E, Klareskog L, Ekbom A, et al. Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives. Arthritis Rheum 2003;48:963-70.
6. Kawashima M, Miossec P. Decreased response to IL-12 and IL-18 of peripheral blood cells in rheumatoid arthritis. Arthritis Res Ther 2004;6:R39-45.